In addition, ALKBH5 deficiency rendered remarkable resistance to gemcitabine treatment in the xenograft mice as measured by increased tumor growth rate, size and Ki67 positive cells compared to control mice (Fig. 2h-k). Here, MKI67 is linked to neoplasm.